Drug Type CAR-T |
Synonyms- |
Target |
Action inhibitors |
Mechanism MSLN inhibitors(Mesothelin inhibitors), Gene transference(Gene transference), T lymphocyte replacements |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Malignant Pleural Mesothelioma | Phase 1 | China | 01 Aug 2016 | |
Mesothelin positive Neoplasms | Phase 1 | China | 01 Aug 2016 | |
Ovarian Cancer | Phase 1 | China | 01 Aug 2016 | |
Pancreatic adenocarcinoma | Phase 1 | China | 01 Aug 2016 |